USD 128.29 Billion
CNS (Central Nervous System) Therapeutics Market Size, Share, Growth Analysis, By Disease(Neurovascular Diseases, CNS Trauma, Mental Health ( Anxiety Disorders, Epilepsy), By Drug Class(Analgesics, Antidepressants, Anesthetics, Anti-Parkinson Drugs), By Distribution Channel(Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2239 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
96
|Figures:
76
CNS (Central Nervous System) Therapeutics Market Insights
CNS (Central Nervous System) Therapeutics Market size was valued at USD 136.37 Billion in 2023 and is poised to grow from USD 144.96 Billion in 2024 to USD 236.34 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).
The Global Central Nervous System (CNS) Therapeutics market is a dynamic and evolving sector within the healthcare and pharmaceutical industry. This market encompasses a wide range of treatments and medications aimed at addressing various neurological and psychiatric disorders. With an increasing understanding of the complexities of the central nervous system and ongoing research and development efforts, this industry continues to see advancements in therapeutic approaches.
Key drivers include the growing awareness of mental health issues and the aging population, which has led to an expanding market for CNS therapeutics. Additionally, the industry is witnessing collaborations and partnerships between pharmaceutical companies and research institutions, fueling innovation in the field.
As technology and science continue to advance, the CNS therapeutics market is expected to play a crucial role in improving the quality of life for individuals affected by these conditions. However, it also faces challenges related to regulatory approvals, pricing pressures, and market competition, which require strategic responses from industry stakeholders.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals Pharmacies
Fastest Growth
Hospitals Pharmacies
Growth Rate
6.30% CAGR
Global CNS (Central Nervous System) Therapeutics market ($Bn)
Country Share for NORTH AMERICA Region (%)
To get more reports on the above market click here to Buy The Report
CNS (Central Nervous System) Therapeutics Market Segmental Analysis
Global CNS (Central Nervous System) Therapeutics Market is segmented By Disease, By Drug Class, By Distribution Channel and Region. Based on Disease, the market can be segmented into Neurovascular Diseases, CNS Trauma, Mental Health ( Anxiety Disorders, Epilepsy, Mood Disorders, Psychotic Disorders and Others), Neurodegenerative Diseases (Alzheimer's Disease, Parkinson’s Disease, Multiple Sclerosis, Huntington's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis and Others), Infectious Diseases, CNS Cancer and Other. Based on Drug Class, the market can be segmented into Analgesics, Antidepressants, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, and Other. Based on Distribution Channel, the market can be segmented into Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Disease Type
Mental health disorders are currently the dominating disease type within the CNS therapeutics market. This dominance can be attributed to increasing awareness, reduced stigma, and a growing understanding of the importance of mental well-being. The prevalence of conditions like depression, anxiety, and schizophrenia has driven demand for effective treatments and medications.
However, Degenerative diseases, such as Alzheimer's and Parkinson's, are among the fastest-growing segments in the CNS therapeutics market. The aging population worldwide has led to a surge in these conditions. As the elderly demographic expands, the need for innovative and more efficacious treatments for degenerative diseases continues to grow, making this segment a focus of significant research and development efforts.
Analysis by Distribution Channel
Hospitals pharmacies currently dominate the distribution channel in the CNS therapeutics market. Hospitals serve as primary centers for the diagnosis and treatment of neurological and psychiatric disorders, making them crucial hubs for dispensing CNS medications. The demand for acute care and specialized treatments drives the preference for hospital pharmacies, where patients often receive initial prescriptions and ongoing management of their conditions.
Moreover, Retail pharmacies are the fastest-growing distribution channel in the CNS therapeutics market. This growth can be attributed to several factors. Firstly, the increasing focus on outpatient care and telemedicine has led to greater demand for medications dispensed through retail channels. Patients prefer the convenience and accessibility of retail pharmacies for prescription refills and routine medication management. Additionally, the shift toward more decentralized healthcare models and the rise of community-based mental health services contribute to the rapid expansion of retail pharmacy distribution.
Global CNS (Central Nervous System) Therapeutics market by Distribution channel
To get detailed analysis on other segments, Request For Free Sample Report
CNS (Central Nervous System) Therapeutics Market Regional Insights
North America currently dominates the CNS therapeutics market in terms of distribution channel. This is primarily due to factors such as a well-established healthcare infrastructure, high healthcare expenditure, and a strong pharmaceutical industry presence. Additionally, the region benefits from advanced research and development capabilities and a relatively higher awareness of neurological and psychiatric disorders.
Moreover, Asia Pacific is experiencing the fastest growth in the CNS therapeutics market distribution channel. The region's rapid economic growth, increasing healthcare investments, and rising patient awareness are driving this growth. Moreover, the presence of a large patient population and expanding pharmaceutical markets in countries like China and India make Asia Pacific a promising hub for CNS therapeutics distribution. The ongoing shift toward urbanization and improved access to healthcare services further contribute to the region's accelerated market expansion.
Global CNS (Central Nervous System) Therapeutics market by Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
CNS (Central Nervous System) Therapeutics Market Dynamics
Drivers
Increasing Aging Population
- As the world's population continues to age, the prevalence of neurological disorders like Alzheimer's and Parkinson's disease rises significantly. This demographic shift leads to a higher demand for CNS therapeutics and treatments, as older individuals are more susceptible to these conditions.
Restraints
Stringent Regulatory Approval Process
- Developing drugs and treatments for neurological and psychiatric disorders involves extensive clinical trials and regulatory hurdles. The rigorous scrutiny by regulatory authorities can lead to delays and increased costs in bringing new therapies to market, which can hinder innovation and timely patient access to effective treatments.
Request Free Customization of this report to help us to meet your business objectives.
CNS (Central Nervous System) Therapeutics Market Competitive Landscape
The competitive landscape within the CNS therapeutics market is characterized by intense rivalry among numerous pharmaceutical and biotechnology companies, each vying to develop and market innovative treatments for central nervous system disorders.
These industry players compete on the basis of research and development capabilities, product efficacy, safety profiles, and market penetration strategies. Collaboration and partnerships with academic institutions and research organizations are common approaches to harness scientific expertise.
Additionally, companies are increasingly investing in marketing and educational campaigns to raise awareness about CNS disorders, aiming to capture a larger share of the expanding patient population seeking treatment. Intellectual property, regulatory approvals, and strategic alliances play pivotal roles in determining the success of firms in this competitive sector.
Top Player’s Company Profiles
- Biogen Inc. (US)
- Otsuka Pharmaceutical Co. Ltd (Japan)
- Eli Lilly and Company (US)
- Merck & Co. (US)
- AstraZeneca (UK)
- Takeda Pharmaceutical Company Limited (Japan)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Johnson & Johnson Private Limited (US)
- Pfizer Inc. (US)
- GlaxoSmithKline PLC (UK)
- Sanofi (France)
- AbbVie Inc. (US)
- Roche Holding AG (Switzerland)
- Bristol-Myers Squibb (US)
- Lundbeck A/S (Denmark)
- Allergan PLC (Ireland)
- Eisai Co., Ltd. (Japan)
- UCB S.A. (Belgium)
- Sunovion Pharmaceuticals Inc. (US)
Recent Developments
-
In June 2022, CNS Pharmaceuticals, Inc. received approval from the U.S. Food and Drug Administration (FDA) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first-line therapy for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.
In January 2022, Otsuka Pharmaceutical Co., Ltd. (Otsuka); its subsidiary Otsuka America Pharmaceutical, Inc.; and Lundbeck, Inc., a U.S. subsidiary of H. Lundbeck A/S in Denmark, announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of REXULTI (brexpiprazole) for the treatment of schizophrenia in pediatric patients 13 to 17 years of age.
In April 2021, Biogen acquired the approval of the National Medical Products Administration for its product TECFIDERA for the treatment of relapsing multiple sclerosis in China.
CNS (Central Nervous System) Therapeutics Key Market Trends
- Emergence of Personalized Medicine in CNS Therapeutics : Advances in genetics and neuroimaging technologies have enabled a deeper understanding of individual variations in CNS disorders. This trend involves tailoring treatments based on a patient's unique genetic makeup, neurobiological profile, and response to therapy, leading to more targeted and effective interventions while minimizing adverse effects. Personalized approaches have the potential to revolutionize the treatment landscape for conditions like Alzheimer's, depression, and schizophrenia, offering a promising avenue for improving patient outcomes in the CNS therapeutics market.
CNS (Central Nervous System) Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global CNS therapeutics market analysis, the market continues to exhibit robust growth driven by several key factors. Increasing awareness of mental health issues, the aging population, and a rising prevalence of neurological disorders are pivotal drivers.
Major pharmaceutical and biotechnology companies are investing heavily in research and development, resulting in innovative treatments. Moreover, strategic collaborations and partnerships are shaping the competitive landscape, fostering innovation and market expansion.
However, the market faces challenges, including stringent regulatory approval processes and pricing pressures. The complex nature of CNS disorders also poses hurdles in drug development. Nevertheless, the market's overall trajectory remains positive, with a growing emphasis on personalized medicine and advancements in neurobiology expected to unlock new opportunities.
Looking ahead, the CNS therapeutics market is poised for continued growth and transformation. Personalized medicine, with its potential to revolutionize treatment approaches, is expected to gain prominence.
Additionally, the integration of digital health technologies and artificial intelligence in diagnostics and treatment monitoring will enhance patient care and outcomes. The emergence of novel therapeutic modalities, such as gene therapies and precision-targeted drugs, holds promise in addressing previously challenging CNS conditions.
As the industry continues to innovate and adapt, it is well-positioned to meet the evolving needs of patients with central nervous system disorders, making a meaningful impact on global healthcare in the coming years.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 128.29 Billion |
| Market size value in 2031 | USD 222.33 Billion |
| Growth Rate | 6.30% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on CNS (Central Nervous System) Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on CNS (Central Nervous System) Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the CNS (Central Nervous System) Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the CNS (Central Nervous System) Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the CNS (Central Nervous System) Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the CNS (Central Nervous System) Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
